| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-07-31 | Ross Jack CEO and Chairman | Purchase | +27,900 | +7.29%410,507 | $2.85 | $79,578 | View SEC filing | |
| 2025-06-13 | Knight Therapeutics Inc 10% Owner | Purchase | +428,570 | +100.00%428,570 | N/A | N/A | View SEC filing | |
| 2025-06-11 | Ross Jack CEO and Chairman | Purchase | +16,100 | +4.39%382,607 | $1.85 | $29,837 | View SEC filing | |
| 2025-05-21 | Ross Jack CEO and Chairman | Purchase | +5,300 | +1.47%366,507 | $2.05 | $10,870 | View SEC filing | |
| 2025-05-21 | Ross Jack CEO and Chairman | Purchase | +14,340 | +4.13%361,207 | $2.74 | $39,350 | View SEC filing | |
| 2025-03-03 | Ross Jack CEO and Chairman | Purchase | +15,200 | +4.58%346,877 | $3.92 | $59,521 | View SEC filing | |
| 2025-03-03 | Ross Jack CEO and Chairman | Purchase | +5,170 | +1.58%331,677 | $4.92 | $25,460 | View SEC filing | |
| 2024-10-24 | Ross Jack CEO and Chairman | Purchase | +300,000 | +100.00%300,000 | $9.00 | $2,700,000 | View SEC filing | |
| 2020-06-02 | Ross Jack President, CEO and CFO | Purchase | +3,000,000 | +184.61%4,625,034 | $0.15 | $450,000 | View SEC filing | |
| 2020-01-21 | Ross Jack President and CEO | Purchase | +228,572 | +14.07%1,853,606 | $0.04 | $9,989 | View SEC filing | |
| 2018-12-21 | Ross Jack President and CEO | Purchase | +1,225,034 | +306.26%1,625,034 | $0.55 | $673,769 | View SEC filing | |
| 2018-12-11 | Ross Jack President and CEO | Purchase | +1,225,034 | +100.00%1,225,034 | $0.55 | $673,769 | View SEC filing | |
| 2015-12-08 | Ross Jack President & CEO | Purchase | +7,936,850 | +21.98%44,053,100 | $0.03 | $198,421 | View SEC filing | |
| 2015-12-08 | Gowan Private Equity Inc. 10% Owner | Purchase | +7,936,850 | +21.98%44,053,100 | $0.03 | $198,421 | View SEC filing | |
| 2015-04-27 | Ross Jack President & CEO | Purchase | +16,522,500 | +100.00%16,522,500 | $0.12 | $1,999,223 | View SEC filing |
1-15 of 15
